FLUCELVAX® QUADRIVALENT helps prevent seasonal influenza in patients 6 months and older.¹

FLUCELVAX QUADRIVALENT (Influenza Vaccine) was proven noninferior to a US-licensed comparator quadrivalent influenza vaccine for patients 6 months through 3 years (Study 1) and noninferior to FLUCELVAX (Influenza Vaccine) for patients 4 through 17 years (Study 5) based on data demonstrating immunogenicity and seroconversion.